Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance

By Clemens R.   Sanger R.   Kruppenbacher J.   Hobel W.   Stanbury W.   Bock H.L.   Jilg W.  

Vaccine, Vol. 15, Iss. 4, 1997-03 ,pp. : 349-352

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a new influenza vaccine grown in mammalian cell culture

By Halperin S.A.   Nestruck A.C.   Eastwood B.J.  

Vaccine, Vol. 16, Iss. 13, 1998-08 ,pp. : 1331-1335

Elsevier

Access to resources Recommend Favorite

Thermostabilization of egg grown influenza viruses

By Ikizler M.R.   Wright P.F.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1393-1399

Elsevier

Access to resources Recommend Favorite

Randomized, comparative trial of 20 g vs 40 g Engerix B vaccine in hepatitis B vaccine non-responders

By Goldwater P.N.  

Vaccine, Vol. 15, Iss. 4, 1997-03 ,pp. : 353-356

Elsevier

Access to resources Recommend Favorite

Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine

By Vodopija R.   Lafont M.   Baklaic Z.   Ljubicic M.   Svjetlicic M.   Vodopija I.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 571-574

Elsevier

Access to resources Recommend Favorite